November 30, 2021 - 5 pm CET
The need for rapid molecular Point-of-care (POC) testing has never been greater. In the face of the COVID-19 pandemic, short development and commercialization timelines play a crucial role in reining in the global health crisis.
Modern POC molecular assays must be fast, reliable, and flexible to perform in any setting without cumbersome storage requirements. Such demands require test reagents to be stable at room temperature in a dried or lyophilized form. The ability to dry down assays often requires laborious reformulation of the reagents. Unfortunately, these additional processing steps lead to increases in enzyme loss, development cost, effort and time.
How to solve this issue? From the start, work with lyo-ready reagents without sacrificing speed or assay performance. At Roche CustomBiotech, we know that great creations need premium ingredients that fit right into your manufacturing process.
Join our webinar and learn how working with Roche CustomBiotech enzymes can reduce your development time and decrease your overall assay time with our latest lyo-ready KAPA3G DNA Polymerase and NxtScript Reverse Transcriptase family of products.*
You are just one step away:
* For further processing only.